| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |